My reflection on 2023 has little to do with specifics. In my view, this was a year of opposite choices and opposing directions – the big stuff. Yet, daily demands to address the urgent (but often not so important) dulled our senses and intuition. Hence, we likely missed or misjudged several major events this year that will surely bring deep change. I offer the following examples.
Given its growing role as the “pharmacy to the world,” FDA Commissioner Robert Califf, M.D., recently took a trip to India and offered some of his (and FDA's) views upon his return..